New York (CNN Business)Gilead Sciences will acquire biopharmaceutical company Immunomedics for $21 billion, the company announced on Sunday. The acquisition will expand Gilead’s portfolio of treatments for various types of cancer.

The deal with Immunomedics provides Gilead (GILD) with Trodelvy, an antibody drug for advanced triple-negative breast cancer. The drug was given accelerated FDA approval in April. Immunomedics will be acquired by $88 per share in cash — more than double the $42.25 at which shares traded on Friday’s close.

“This acquisition represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio,” Gilead Chairman and CEO, Daniel O’Day said in a statement. “Trodelvy is an approved, transformational medicine for a form of cancer that is particularly challenging to treat. We will now continue to explore its potential to treat many other types of cancer, both as a monotherapy and in combination with other treatments.”

The deal is anticipated to close in the fourth quarter of 2020, according to the companies. The dealwill be funded by $15 billion in cash on hand and roughly $6 billion in newly issued debt, Gilead said.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Alibaba stock spikes after Jack Ma resurfaces

After rumors and speculation swirled that Jack Ma was allegedly missing, the Alibaba founder and Chinese billionaire has resurfaced in an online video. After Ma’s reappearance video was shared online Wednesday, Alibaba stock soared by more than 7%. It had…

Emails: Companies urged gov to veto anti-LGBT adoption law

NASHVILLE, Tenn. — As Tennessee Gov. Bill Lee’s office sought to downplay potential consequences over an anti-LGBT adoption proposal, multiple big companies reached out to his administration warning the state’s reputation would suffer if the Republican were to enact it.…

Reports: Nissan failed to report income for Ghosn in Japan

TOKYO — The case against former Nissan executive Carlos Ghosn may have taken another turn as Japanese media report allegations that the automaker declared as expenses 1.15 billion yen ($10.8 million) in his taxable personal income. Japan’s National Tax Agency…

Wirecard collapses owing creditors $4 billion

BERLIN/MUNICH/FRANKFURT (Reuters) – German payments company Wirecard collapsed on Thursday after disclosing a massive financial hole in its books, leaving creditors owed nearly $4 billion facing an almost complete wipeout. The implosion of the fintech company comes less than two…